Author(s): Couto, J. ; Antunes, S. ; Ferrolho, J. ; De La Fuente, J. ; Domingos, A.
Date: 2017
Origin: Repositório Institucional da UNL
Subject(s): Transmission-blocking vaccines; Plasmodium vivax; Salivary-glands; Aedes aegypyi; Malaria; Protein; Sporozoites; Falciparum; Resistance; Alignment; Immunology and Microbiology(all); Biochemistry, Genetics and Molecular Biology(all); Infectious Diseases; Insect Science; SDG 3 - Good Health and Well-being
Despite the fact that recent efforts to control/eradicate malaria have contributed to a significant decrease in the number of cases and deaths, the disease remains a global health challenge. Vaccines based on mosquito salivary gland antigens are a potential approach for reducing vector populations and malaria parasites. The Anopheles AGAP007752 gene encodes for a glucose transporter that is upregulated during Plasmodium infection, and its knockdown decreases the number of sporozoites in mosquito salivary glands. These results together with the fact that glucose is a vital source of energy suggested that a glucose transporter is a candidate protective antigen for the control of mosquito infestations and Plasmodium infection. To address this hypothesis, herein we investigate the effect of mice vaccination with an immunogenic peptide from mosquito glucose transporter on Anopheles stephensi fitness and Plasmodium berghei infection. We showed that vaccination with a peptide of glucose transporter reduced mosquito survival by 5% when compared to controls. However, the reduction in Plasmodium infection was not significant in mosquitoes fed on vaccinated mice. The effect of the peptide vaccination on mosquito survival is important to reduce infestation by malaria vectors. These results support further research on developing glucose transporter-based vaccines to reduce mosquito fitness.
